Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 EUR | -1.39% | +1.43% | -9.84% |
Mar. 06 | Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 06 | Transcript : Herantis Pharma Oyj, 2023 Earnings Call, Mar 06, 2024 |
Sales 2024 * | 1.3M 1.4M | Sales 2025 * | - | Capitalization | 28.63M 30.76M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.22M | Net income 2025 * | -4M -4.3M | EV / Sales 2024 * | 18.8 x |
Net cash position 2024 * | 4.2M 4.51M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.93% |
Latest transcript on Herantis Pharma Oyj
1 day | -1.39% | ||
1 week | +1.43% | ||
Current month | +1.43% | ||
1 month | -3.73% | ||
3 months | +4.41% | ||
6 months | -16.22% | ||
Current year | -9.84% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 07-12-31 | |
Antti Vuolanto
CEO | Chief Executive Officer | - | 18-02-11 |
Tone Kvåle
DFI | Director of Finance/CFO | 55 | 20-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 53 | 13-12-31 | |
Director/Board Member | 53 | 20-03-10 | |
Chairman | 64 | 11-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1.42 | -1.39% | 1,036 |
24-05-07 | 1.44 | +1.77% | 4,551 |
24-05-06 | 1.415 | 0.00% | 6,987 |
24-05-03 | 1.415 | +1.80% | 12,418 |
24-05-02 | 1.39 | -0.71% | 2,088 |
Delayed Quote Nasdaq Helsinki, May 08, 2024 at 11:29 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.84% | 30.77M | |
+2.93% | 108B | |
+7.02% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- HRTIS Stock